Top Markets
Coin of the day
Microbix Biosystems Inc. Microbix Biosystems Inc.

Microbix Biosystems Inc.

MBX
Rangering i aksjer #28067
Microbix Biosystems Inc. is a life science enterprise dedicated to advancing... Microbix Biosystems Inc. is a life science enterprise dedicated to advancing human health globally, including markets across North America and Europe. Established in 1988 and headquartered in Mississauga, Canada, the company specializes in developing and marketing unique biological and technological products. A significant part of its business involves producing essential biological reagents for the diagnostic industry. This encompasses antigens vital for immunoassays, alongside its distinctive Quality Assessment and Proficiency (QAP) products. These QAPs are instrumental for clinical laboratories, providing support for proficiency testing, the development and validation of diagnostic assays, and optimizing routine lab operations. Furthermore, Microbix applies its deep biological knowledge and infrastructure to create additional proprietary offerings. Among these are DxTM, a viral transport medium crucial for stabilizing patient specimens prior to laboratory analysis, and Kinlytic Urokinase, a biopharmaceutical thrombolytic drug employed to treat blood clots. The company channels its QAP sales to accreditation organizations, diagnostic companies, and clinical laboratories via an extensive network of regional distributors.
Aksjekurs
$0.20917201
Sist synkronisert: 2026-08-19
Markedsverdi
$28.76M
Endring (1 dag)
-1.72%
Endring (1 år)
23.48%
Land
CA
Handel Microbix Biosystems Inc. (MBX)

Kategori

P/S-forhold for Microbix Biosystems Inc. (MBX)
P/S-forhold per 2026 TTM: 0
Ifølge Microbix Biosystems Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Microbix Biosystems Inc. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
10.17 -
US
11.28 -
US
10.13 -
NL
2.95 -
AU
- -
CH